![Robert Williamson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Williamson
Directeur/Membre du Conseil chez
PERSPECTIVE THERAPEUTICS, INC.
Fortune : 405 265 $ au 30/06/2026
Profil
Robert F.
Williamson is the founder of LaSalle Venture Advisers, founded in 2002.
Mr. Williamson is the founder of Aegle Therapeutics Corp., founded in 2013, serving as Chief Financial Officer & Director.
Current jobs include President, Chief Executive Officer & Director at Sidecar Therapeutics, Inc.; Director at Clarke Industrial Engineering, Inc.; President, Chief Operating Officer & Director at Triumvira Immunologics USA, Inc. since 2022; Independent Director at Perspective Therapeutics, Inc. since 2023; and Member-Coulter Oversight Board at the University of Miami.
Former jobs include Chief Executive Officer & Director at Arriva Pharmaceuticals, Inc. (2006); Acting Chief Executive Officer at BrainCells, Inc.; Chief Executive Officer at ATXCo, Inc.; Chief Executive Officer & Director at PharmAkea, Inc. (2013–2019); President, Chief Executive Officer & Director at BioTheryX, Inc. (2020–2021); Executive Chairman at Strategic Enzyme Applications, Inc. (2008–2013); Executive Chairman at HAYA Therapeutics SA (2021–2022); Independent Director at Pharmasset, Inc. (2012); Director at TBG Diagnostics Ltd. (2008–2009); Director at IsoRay, Inc.; Director at Viewpoint (US); President & Chief Operating Officer at DoubleTwist, Inc. (1999–2002); Partner at The Boston Consulting Group, Inc. (1991–1999); President & Chief Operating Officer at EOS Biotechnology, Inc. (2002–2004); Research Assistant at Federal Reserve System (1987–1989); Chief Financial Officer at Oncomyx Therapeutics, Inc. (2022).
Education includes undergraduate degree from Pomona College and MBA from Stanford University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 02/04/2026 | 118 846 ( 0,1 % ) | 405 265 $ | 30/06/2026 |
Postes actifs de Robert Williamson
| Sociétés | Poste | Début |
|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 05/02/2023 |
Sidecar Therapeutics, Inc.
 Sidecar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur Général | - |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Triumvira Immunologics USA, Inc.
 Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures novel T cell therapies for cancer | President | 24/10/2022 |
Aegle Therapeutics Corp.
 Aegle Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing extracellular vesicle therapeutics | Fondateur | 01/01/2013 |
Clarke Industrial Engineering, Inc.
 Clarke Industrial Engineering, Inc. Industrial MachineryProducer Manufacturing Manufactures shutter valves | Directeur/Membre du Conseil | - |
Anciens postes connus de Robert Williamson
| Sociétés | Poste | Fin |
|---|---|---|
HAYA Therapeutics SA
 HAYA Therapeutics SA BiotechnologyHealth Technology Develops RNA-based therapeutics to treating fibrotic diseases | Président | 14/09/2022 |
Oncomyx Therapeutics, Inc.
 Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and operates software platform to orchestrate an immune response & treat cancer | Directeur Financier/CFO | 01/09/2022 |
BioTheryX, Inc.
 BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Directeur Général | 01/01/2021 |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Robert Williamson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
25
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
DoubleTwist, Inc.
 DoubleTwist, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genomic information and bioinformatics analysis | Commercial Services |
Arriva Pharmaceuticals, Inc.
 Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory therapies for treating respiratory diseases | Health Technology |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
BrainCells, Inc.
 BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
BioTheryX, Inc.
BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Technology Services |
PharmAkea, Inc.
 PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drug candidates against protein targets involved in fibroproliferative diseases | Health Technology |
Clarke Industrial Engineering, Inc.
Clarke Industrial Engineering, Inc. Industrial MachineryProducer Manufacturing Manufactures shutter valves | Producer Manufacturing |
Pomona College
 Pomona College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TBG Diagnostics Ltd.
 TBG Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule pharmaceuticals for the treatment of cancer | Health Technology |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
EOS Biotechnology, Inc.
 EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs | Health Technology |
University of Miami
University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Federal Reserve System
 Federal Reserve System General GovernmentGovernment Federal reserve bank | Government |
IsoRay, Inc.
 IsoRay, Inc. Medical SpecialtiesHealth Technology Produces therapeutic radioactive isotopes | Health Technology |
LaSalle Venture Advisers | |
Strategic Enzyme Applications, Inc.
 Strategic Enzyme Applications, Inc. Chemicals: SpecialtyProcess Industries Manufactures organic chemicals | Process Industries |
Sidecar Therapeutics, Inc.
Sidecar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Oncomyx Therapeutics, Inc.
Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and operates software platform to orchestrate an immune response & treat cancer | Technology Services |
ATXCo, Inc.
 ATXCo, Inc. Pharmaceuticals: OtherHealth Technology Develops clinical programs for the inhibition of fibrotic diseases | Health Technology |
Aegle Therapeutics Corp.
Aegle Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing extracellular vesicle therapeutics | Health Technology |
Viewpoint (US) | |
HAYA Therapeutics SA
HAYA Therapeutics SA BiotechnologyHealth Technology Develops RNA-based therapeutics to treating fibrotic diseases | Health Technology |
Triumvira Immunologics USA, Inc.
Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures novel T cell therapies for cancer | Commercial Services |
Perspective Therapeutics, Inc.
 Perspective Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical technology devices | Health Technology |
Choisissez Zonebourse 
